News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Upgrades MEDBOT-B to Buy on Strong Overseas Sales, Expects Breakeven in 1H26
According to a report from UBS, the broker was bullish on MEDBOT-B (02252.HK)'s strong overseas sales potential.MEDBOT-B's overseas revenue surged by 287% YoY last year, wi...
Reset
Send
The window will close in 5 seconds
<Research>UBS Upgrades MEDBOT-B to Buy on Strong Overseas Sales, Expects Breakeven in 1H26
Close
Recommend
5
Positive
4
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

According to a report from UBS, the broker was bullish on MEDBOT-B (02252.HK)  -0.800 (-2.410%)    Short selling $7.06M; Ratio 4.056%   's strong overseas sales potential.

MEDBOT-B's overseas revenue surged by 287% YoY last year, with sales volume of its Toumai surgical robot increasing more than fivefold. Unlike developed markets, the company focuses on middle-income developing countries in South America, South Asia, and Central and Eastern Europe, where penetration of surgical robots remains low and demand is substantial.

In UBS' estimation, these regions will see cumulative installation demand for more than 10,000 laparoscopic surgical robots. As one of the market pioneers, MEDBOT-B is likely to capture a 25% market share.

MEDBOT-B aims to double its total revenue in 2026 from 2025 and hike the overseas revenue contribution from 73% last year to over 80%, making it possible to achieve breakeven in 1H26.

UBS has increased its target price for MEDBOT-B from HKD21.4 to HKD35.9 and upgraded its rating from Neutral to Buy.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-24 16:25.)

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.